Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -108.22%-38.12M | -19,908.11%-14.81M | -128.81%-1.9M | 44.84%-7.06M | -19.49%-14.36M | 62.58%-18.31M | 99.30%-74K | 202.91%6.58M | 47.70%-12.8M | -59.61%-12.02M |
Net income from continuing operations | -318.28%-295.55M | -364.35%-146.49M | -404.48%-12.18M | 30.53%-11.74M | -377.41%-125.15M | 36.55%-70.66M | -61.05%-31.55M | 124.82%4M | 70.28%-16.9M | -39.25%-26.21M |
Operating gains losses | 1,784.82%138.93M | 1,229.81%124.1M | 91.84%-1.28M | -352.55%-7.88M | 126.87%23.99M | 134.46%7.37M | 147.08%9.33M | -15,250.00%-15.66M | 1,668.34%3.12M | 937.29%10.58M |
Depreciation and amortization | 50.27%11.87M | 59.44%3.13M | 72.20%3.39M | 46.89%2.91M | 22.81%2.44M | 1.84%7.9M | -1.45%1.97M | -3.29%1.97M | 1.28%1.98M | 12.08%1.99M |
Deferred tax | -39.57%-328K | -1.04%-291K | --0 | -1,300.00%-14K | -142.59%-23K | 87.79%-235K | 39.24%-288K | --0 | 99.94%-1K | -68.97%54K |
Other non cash items | 6.44%14.15M | 6.60%12.08M | 5.46%695K | -7.52%775K | 29.03%600K | 9.56%13.29M | 7.27%11.33M | 26.00%659K | 59.92%838K | -11.09%465K |
Change In working capital | -475.24%-13.55M | -524.15%-12.4M | -79.03%2.26M | 148.24%3.14M | -83.42%-6.55M | 615.05%3.61M | 239.39%2.92M | 120.59%10.77M | 23.54%-6.51M | -157.28%-3.57M |
-Change in receivables | -370.52%-7.83M | -313.57%-5.51M | -98.12%133K | 285.95%4.06M | -42.10%-6.51M | 366.88%2.89M | 64.06%2.58M | 322.18%7.08M | -354.96%-2.19M | -1,310.46%-4.58M |
-Change in prepaid assets | -64.81%2.08M | 290.07%536K | -68.30%297K | -92.20%293K | -36.16%950K | 446.59%5.9M | 94.63%-282K | -68.91%937K | 3,546.60%3.76M | 244.44%1.49M |
-Change in payables and accrued expense | -294.96%-6.9M | -345.16%-6.29M | -11.80%2.78M | 99.49%-34K | -296.34%-3.36M | -136.24%-1.75M | -33.71%2.56M | 21.83%3.15M | 27.23%-6.62M | -111.37%-848K |
-Change in other current liabilities | 38.28%-1.41M | -135.01%-1.17M | 103.98%29K | 25.92%-826K | 1,024.49%551K | -203.67%-2.29M | -210.44%-497K | -151.20%-728K | -537.25%-1.12M | -40.96%49K |
-Change in other working capital | 144.97%514K | 101.94%28K | -407.19%-983K | -2.88%-357K | 461.85%1.83M | 69.44%-1.14M | 47.33%-1.44M | -69.35%320K | 45.18%-347K | 122.97%325K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -108.22%-38.12M | -19,908.11%-14.81M | -128.81%-1.9M | 44.84%-7.06M | -19.49%-14.36M | 62.58%-18.31M | 99.30%-74K | 202.91%6.58M | 47.70%-12.8M | -59.61%-12.02M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 173.66%2.82M | -214.94%-3.41M | -57.00%-4.31M | -85,450.00%-1.71M | 12.25M | 26.82%-3.83M | -3,184.85%-1.08M | -765.62%-2.74M | 99.96%-2K | 0 |
Capital expenditure reported | -177.69%-10.63M | -198.34%-3.23M | -52.00%-4.17M | ---1.58M | ---1.64M | ---3.83M | ---1.08M | ---2.74M | --0 | --0 |
Net PPE purchase and sale | -24,100.00%-484K | ---180K | ---137K | -6,350.00%-129K | ---38K | 99.74%-2K | --0 | --0 | 98.66%-2K | --0 |
Net business purchase and sale | --13.94M | --0 | --0 | --0 | --13.94M | --0 | --0 | --0 | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 173.66%2.82M | -214.94%-3.41M | -57.00%-4.31M | -85,450.00%-1.71M | --12.25M | 26.82%-3.83M | -3,184.85%-1.08M | -765.62%-2.74M | 99.96%-2K | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 24.72%52.46M | 49.90%2.3M | 73.33%-420K | -101.80%-377K | 140.24%50.96M | 140.78%42.06M | 23.67%1.53M | -35.43%-1.58M | 1,905.88%20.89M | 120.78%21.21M |
Net issuance payments of debt | 50.36%-412K | -33.52%817K | 20.11%-417K | 47.16%-409K | 47.18%-403K | 61.82%-830K | -4.73%1.23M | 54.69%-522K | 32.87%-774K | 34.17%-763K |
Net common stock issuance | --0 | --0 | --0 | --0 | --0 | 143.88%44.28M | --0 | ---499K | --19.78M | 124.78%25M |
Proceeds from stock option exercised by employees | 4,627.64%55.6M | 64.65%1.06M | --0 | --640K | --53.9M | --1.18M | --645K | --531K | --0 | --0 |
Net other financing activities | -6.52%-2.73M | 221.28%416K | 99.72%-3K | -132.12%-608K | 16.30%-2.53M | -3,720.90%-2.56M | -559.62%-343K | -9,763.64%-1.09M | --1.89M | ---3.03M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 24.72%52.46M | 49.90%2.3M | 73.33%-420K | -101.80%-377K | 140.24%50.96M | 140.78%42.06M | 23.67%1.53M | -35.43%-1.58M | 1,905.88%20.89M | 120.78%21.21M |
Net cash flow | ||||||||||
Beginning cash position | 157.73%32.56M | 103.78%65.58M | 141.51%72.27M | 272.99%81.41M | 157.73%32.56M | -92.57%12.63M | 46.59%32.18M | 0.32%29.92M | -63.61%21.83M | -92.57%12.63M |
Current changes in cash | -13.88%17.16M | -4,369.44%-15.93M | -392.97%-6.62M | -212.97%-9.15M | 431.32%48.86M | 112.67%19.93M | 104.00%373K | 128.71%2.26M | 126.85%8.1M | 108.36%9.2M |
Effect of exchange rate changes | --424K | --482K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
End cash Position | 54.01%50.14M | 54.01%50.14M | 103.78%65.58M | 141.51%72.27M | 272.99%81.41M | 157.73%32.56M | 157.73%32.56M | 46.59%32.18M | 0.32%29.92M | -63.61%21.83M |
Free cash flow | -122.40%-49.23M | -1,473.40%-18.22M | -261.73%-6.2M | 31.48%-8.77M | -33.48%-16.04M | 55.45%-22.14M | 89.04%-1.16M | 157.93%3.84M | 48.01%-12.8M | -52.35%-12.02M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |